ArticlePharmaceutics2023

Design and Characterization of a Novel Venetoclax-Zanubrutinib Nano-Combination for Enhancing Leukemic Cell Uptake and Long-Acting Plasma Exposure.

James Griffin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.